ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Indian drugmakers may suffer profit drop as coronavirus threatens China supplies

Inventory of pharmaceutical ingredients may barely last for two more months

Most companies such as Sun Pharmaceutical Industries and Cipla are well stocked up with inventory up until the first quarter.   © Reuters
| India

MUMBAI (NewsRise) -- The uncontained spread of the new coronavirus poses a fresh threat to the profitability of Indian drug makers, whose inventory of pharmaceutical ingredients may barely last for two more months.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close